Vrouenraets Lieke Josephina Jeanne Johanna, Fredriks A Miranda, Hannema Sabine E, Cohen-Kettenis Peggy T, de Vries Martine C
Department of Pediatric and Adolescent Psychiatry, Curium-Leiden University Medical Centre, Endegeesterstraatweg 27, 2342 AK, Oegstgeest, The Netherlands.
Department of Pediatrics, Leiden University Medical Centre, Leiden, The Netherlands.
Arch Sex Behav. 2016 Oct;45(7):1697-703. doi: 10.1007/s10508-016-0764-9. Epub 2016 Jun 1.
International guidelines recommend the use of Gonadotropin-Releasing Hormone (GnRH) agonists in adolescents with gender dysphoria (GD) to suppress puberty. Little is known about the way gender dysphoric adolescents themselves think about this early medical intervention. The purpose of the present study was (1) to explicate the considerations of gender dysphoric adolescents in the Netherlands concerning the use of puberty suppression; (2) to explore whether the considerations of gender dysphoric adolescents differ from those of professionals working in treatment teams, and if so in what sense. This was a qualitative study designed to identify considerations of gender dysphoric adolescents regarding early treatment. All 13 adolescents, except for one, were treated with puberty suppression; five adolescents were trans girls and eight were trans boys. Their ages ranged between 13 and 18 years, with an average age of 16 years and 11 months, and a median age of 17 years and 4 months. Subsequently, the considerations of the adolescents were compared with views of clinicians treating youth with GD. From the interviews with the gender dysphoric adolescents, three themes emerged: (1) the difficulty of determining what is an appropriate lower age limit for starting puberty suppression. Most adolescents found it difficult to define an appropriate age limit and saw it as a dilemma; (2) the lack of data on the long-term effects of puberty suppression. Most adolescents stated that the lack of long-term data did not and would not stop them from wanting puberty suppression; (3) the role of the social context, for which there were two subthemes: (a) increased media-attention, on television, and on the Internet; (b) an imposed stereotype. Some adolescents were positive about the role of the social context, but others raised doubts about it. Compared to clinicians, adolescents were often more cautious in their treatment views. It is important to give voice to gender dysphoric adolescents when discussing the use of puberty suppression in GD. Otherwise, professionals might act based on assumptions about adolescents' opinions instead of their actual considerations. We encourage gathering more qualitative research data from gender dysphoric adolescents in other countries.
国际指南建议,对于患有性别焦虑症(GD)的青少年,使用促性腺激素释放激素(GnRH)激动剂来抑制青春期。对于患有性别焦虑症的青少年自身如何看待这种早期医学干预,我们知之甚少。本研究的目的是:(1)阐明荷兰患有性别焦虑症的青少年对于使用青春期抑制治疗的考虑因素;(2)探究患有性别焦虑症的青少年的考虑因素是否与治疗团队中的专业人员不同,若不同,在哪些方面不同。这是一项定性研究,旨在确定患有性别焦虑症的青少年对于早期治疗的考虑因素。除一名青少年外,其余13名青少年均接受了青春期抑制治疗;其中五名青少年为跨性别女孩,八名青少年为跨性别男孩。他们的年龄在13岁至18岁之间,平均年龄为16岁11个月,年龄中位数为17岁4个月。随后,将青少年的考虑因素与治疗患有性别焦虑症青少年的临床医生的观点进行了比较。从对患有性别焦虑症青少年的访谈中,出现了三个主题:(1)难以确定开始青春期抑制治疗的合适下限年龄。大多数青少年发现很难界定合适的年龄限制,并将其视为一个两难问题;(2)缺乏青春期抑制治疗长期影响的数据。大多数青少年表示,缺乏长期数据过去没有、将来也不会阻止他们想要接受青春期抑制治疗;(3)社会环境的作用,其中有两个子主题:(a)电视和互联网上媒体关注度的增加;(b)一种强加的刻板印象。一些青少年对社会环境的作用持积极态度,但另一些青少年对此表示怀疑。与临床医生相比,青少年在治疗观点上往往更为谨慎。在讨论对患有性别焦虑症的青少年使用青春期抑制治疗时,听取他们的意见很重要。否则,专业人员可能会基于对青少年意见的假设而非他们的实际考虑来采取行动。我们鼓励从其他国家患有性别焦虑症的青少年那里收集更多定性研究数据。